blood bank Msq-2(4).pdf

1. Whi choft hef oll owi ngst atement sist rue? A.Ani ndi vi dual wit htheBOgenot ypei shomozy...

1. Whi choft hef oll owi ngst atement sist rue? A.Ani ndi vi dual wit htheBOgenot ypei shomozy gousf orBant igen B.Ani ndi vi dual wit htheBBgenot ypei shomozy gousf orBant igen C.Ani ndi vi dual wit htheOOgenot ypei shet eroz ygousf orOant igen D.Ani ndi vi dual wit htheABphenot ypei shomozy gousf orAandBant igens 2. Whi chgenot ype( s)wi l lgi ver iset otheBombayphenot ype? A.HHonl y B.HHandHh C.Hhandhh D.hhonl y 3. Whatbl oodt ypei snotpossi blef oranof fspr ingofanAOandBOmat ing? A.AB B.AorB C.O D.Al lar epossi ble 4. Whi choft hef oll owi ngdi sti ngui shesA1f rom A2 bl oodgr oups? A.A2ant igenwi l lnotr eactwi thant i- A,A1wi l lreactst rongl y(4+) B.AnA2per sonmayf orm ant i- A1; anA1per sonwi l lnotf orm ant i- A1 C.AnA1per sonmayf orm ant i- A2, anA2per sonwi l lnotf orm ant i- A1 D.A2anti genwi l lnotr eactwi thant i- Afr om anoni mmuni zeddonor ;A1wi l lreactwi th anyant i- A 5. Whatant ibodi esar efor medbyaBombayi ndi vi dual ? A.Ant i- Aandant i- B B.Ant i- H C.Ant i- A,B D.Ant i- A,B, andH 6. Whi chbl oodgr ouphast hel eastamountofHant igen? A.A1B B.A2 C.B D.A 7.Whatt ypeRBCscanbet ransf usedt oanA2per sonwi thant i- A1? A.Aonl y B.AorO C.B D.AB 8. WhatABOt ypesmaydonat etoanyot herABOt ype? A.Anegat ive, Bnegat ive, ABnegat ive, Onegat ive B.Onegat ive C.ABnegat ive D.ABnegat ive, Anegat ive, Bnegat ive 9. Howi sani ndi vi dual wit hgenot ypeDce/ dcecl assi fi ed? A.Rhposi ti ve B.Rhnegat ive C.Rhnul l D.Tot alRh 10. Whati sonepossi blegenot ypef orapat ientwhodev elopsant i- Cant ibody ? A.R1r B.R1R1 C.r ´r D.r r 11. TheWi enernomencl atur efort heEant igeni s: A.hr ´ B.hr v´ C.r h˝ D.Rh0 12. Whi chgr oupofant ibodi esi scommonl yfoundascol daggl uti nins? A.Ant i- K,ant i- k,ant i- Jsb B.Ant i- D,ant i- e,ant i- C C.Ant i- M,ant i- N D.Ant i- Fya, ant i- Fyb 13.Whichant ibodyi sfr equent lyseeni npat ient swi thwar m aut oimmunehemol yti c anemia? A.Ant i- Jka B.Ant i- e C.Ant i- K D.Ant i- Fyb 14. Thek(Cel l ano)ant igenisahigh-f requencyantigenandisfoundonmostr edcel l s. How of tenwoul doneex pectt ofindthecorrespondingant ibody? A.Of ten, becausei tisahi ghf requencyant ibody B.Rarel y,becausemosti ndi vi dual shav etheant igenandt her efor ewoul dnotdev elop theanti body C.I tdependsuponthepopul ati on, becausecer tai nraci alandet hni cgr oupsshowa hi gherf requencyofant i- k D.I mpossi blet odet ermi newi thoutconsul ti ngr egi onal bloodgr oupant igenchar ts 15. Whi chgenot ypei shet eroz ygousf orC? A.DCe/ dce B.DCE/ DCE C.Dce/ dce D.DCE/ dCe 16. Ifant i- Kreact s3+withadonorcel lwi thagenot ypeKKand2+wi thaKkcel l ,the ant ibodyi sdemonst rat ing: A.Dosage B.Li nkagedi sequi l ibr ium C.Homozy gosi ty D.Het erozy gosi ty 17. Whattypeofser ologi cal test ingdoesthebl oodbankt echnol ogi stper for m when det ermi ningthebl oodgroupofapati ent? A.Genot ypi ng B.Phenot ypi ng C.Bot hgenot ypi ngandphenot ypi ng D.Pol ymer asechai nreact ion 18. Whi choft hef oll owi ngdescr ibest heexpr essi onofmostbl oodgr oupant igens? A.Domi nant B.Recessi ve C.Codomi nant D.Cor ecessi ve 19.Apati ent ’sserum i sincompat ibl ewi thOcel ls.Thepat ientRBCsgiveanegat ive react iont oant i -Hlect in.Whati sthemostl i kel ycauseoftheseresul ts? A.Thepat ientmaybeasubgr oupofA B.Thepat ientmayhav eani mmunodef ici ency C.Thepat ientmaybeaBombay D.Thepat ientmayhav edev elopedal l oant ibodi es 20. Acqui redBant igenshav ebeenf oundi n: A.Bombayi ndi vi dual s B.Gr oupOper sons C.Al lbl oodgr oups D.Gr oupAper sons 21. Whi cht ypi ngr esul tsar emostl i kel ytooccurwhenapat ienthasanacqui redB ant igen? A.Ant i- A4+, ant i- B-3+, A1cel l sneg, Bcel l sneg B.Ant i- A3+, ant i- Bneg, A1cel l sneg, Bcel l sneg C.Ant i- A4+, ant i- B1+, A1cel l sneg, Bcel l s4+ D.Ant i- A4+, ant i- B4+, A1cel l s2+, Bcel l sneg 22. Whatshoul dbedonei fal lfor war dandr ever se ABOr esul tsaswel last heaut ocont rol areposi ti ve? A.Washt hecel l swi thwar m sal i ne, aut oadsor btheser um at4° C B.Ret ypet hesampl eusi ngadi ff erentl otnumberofr eagent s C.Usepol ycl onal typi ngr eagent s D.Repor tthesampl easgr oupAB 23. Whatshoul dbedonei fal lfor war dandr ever seABOr esul tsar enegat ive? A.Per for m addi ti onal test ingsuchast ypi ngwi thant i- A1l ect inandant i- A,B B.I ncubat eat22° Cor4° Ctoenhanceweakexpr essi on C.Repeatt het estwi thnewr eagent s D.Runanant ibodyi denti fi cati onpanelBl oodbank/Ev aluatel abor ator yandcl i nical dat atospeci fyaddi ti onaltest s/RBCs/ ABOdiscr epancy/3 24. Whyi stest ingf orRhant igensandant ibodi esdi ff erentf rom ABOt est ing? A.ABOreacti onsar eprimari lyduetoIgM ant ibodi esandusual lyoccuratr oom temper atur e;Rhanti bodiesareIgGandaggluti nat ionusual l yrequi resa37°C i ncubat ionandenhancementmedi a B.ABOantigensareatt achedtoreceptor sont heoutsi deoftheredcel landdonot requi reanyspecial enhancementfortest ing; Rhant i gensareloosel yat tachedt othe redcell membr aneandrequi reenhancementfordetecti on C.BothABOandRhant i gensandantibodieshavesimi larst ruct ures,butRh ant ibodi esareconf igur edsothatspecialt echniquesar eneededtof aci li tat ebi ndi ng toRhanti gens D.Ther eisnodi ffer encei nABOandRht esti ng;bot hmaybeconduct edatr oom temper atur ewit hnospeci alenhancementneededf orr eact ion 25. Whi choft hef oll owi nggenot ypeswoul dexpl ainRBCst ypedasgr oupALe( a+b–) ? a.A/ OLel eHHSese b.A/ ALel eHHsese c.A/ OLeLehhSeSe d.A/ ALeLehhsese 26. Whi choft hef oll owi ngr edcel lant igensar efoundongl ycophor in- B A.M, N B.Lea, Leb C.S, s D.P, P1, Pk 27.I faper sonhasthegenet icmakeupHh, AO, LeLe, sese, whatsubst ancewi l lbe foundi nthesecr eti ons? A.Asubst ance B.Hsubst ance C.Leasubst ance D.Lebsubst ance 28. Whichoft hef oll owi ngant igensi sdest roy ed( weakerr eact ion)bypr oteol yti c enzy mes? A.M B.Lea C.N D.Twooft heabov e 29. ALewi sphenot ypet hatcont ainsr edcel l sA, BorHant igensofanon- secr etorwi l l mostl i kel yty peas: A.Le( a-b- ) B.Le( a+b+) C.Le( a+b- ) D.Le( a-b+) 30. Whi choft hef oll owi ngchar act eri sti cbestdescr ibesLewi sant ibodi es? A.I gM, nat ural l yoccur ri ng, causeHDFN( Hemol yti cDi seaseoft heNewbor n/Fet us) B.I gM,natur all yoccur ri ng, donotcauseHDFN( Hemol yti cDi seaseoft he Newbor n/Fetus) C.I gG, inv itr ohemol ysi s,causeshemol yti ctr ansf usi onr eact ions D.I gG, inv itr ohemol ysi s,donotcausehemol yti c 31. Whatt ype( s)ofr edcel l sis( are)accept abl etot ransf uset oanO- negat ivepat ient ? A.Anegat ive, Bnegat ive, ABnegat ive, orOnegat ive B.Onegat ive C.ABnegat ive D.ABnegat ive, Anegat ive, Bnegat ive 32. Howlongmustareci pientsampl ebekepti nthebl oodbankf oll owi ng compat ibi l ityt est ing? A.3day s B.5day s C.7day s D.10day s 33. Whati sthecr ossmat chi ngpr otocol forpl atel etsand/ orpl asma? A.Per for m ar ever segr oupi ngondonorpl asma B.Not est ingi srequi red C.Per for m ar ever segr oupi ngonr eci pientpl asma D.Pl atel etsmustbeHLAcompat ibl e 34.Whatmaybefoundintheser um ofaper sonwhoi sex hibi ti ngsi gnsofTRALI (t ransf usi on- rel atedacutelungi njur y)? A.Redbl oodcel lal l oant ibody B.I gAant ibody C.Ant il eukocy teant ibody D.Al l ergen 36.Whichty peoftransf usionreacti onoccur sinabout1%ofal lt ransf usi ons, resul ts i nat emperatur er i seof1°Corhigher, isassoci atedwit hbloodcomponent tr ansfusi on,andisnotr elatedtothepati ent ’smedical condit ion? A.I mmedi atehemol yti c B.Del ayedhemol yti c C.Febr il enonhemol yti creact ion D.Tr ansf usi on- rel atedacut elungi njur y 37. All oft hef oll owi ngst atement sregar dingFFPar etr ue, except : A.FFPmustbepr epar edwi thi n24hour sofcol l ect ion B.Af tert hawi ng, FFPmustbet ransf usedwi thi n24hour s C.St oraget emper atur eforFFPwi tha1- yearshel fli fei s≤−18° C D.Whent hawed, FFPmustbest oredbet ween1° C–6° C 38. Cry opr eci pit atemaybeusedt otr eatal loft hef oll owi ng, except : A.v onWi l lebr and’ sdi sease B.Hy pof ibr inogenemi a C.I diopat hict hrombocy topeni cpur pur a(I TP) D.Fact orXI IIdef ici ency 39. Whi chcomponenthast hel ongestexpi rat iondat e? A.Cr yopr eci pit ate B.FFP C.Fr ozenRBCs D.Pl atel etconcent rat es 40. Whati saspeci alcondi ti onf ort hest orageofpl atel ets? A.Room t emper atur e,20° C–24° C B.Noot hercomponent smaybest oredwi thpl atel ets C.Pl atel etsmustbest oredupr ighti nsepar atecont ainer s D.Pl atel etsr equi reconst antagi tat ionat20° C–24° C 41. Whatmar keri sthef ir stt oappeari nhepat it isBi nfect ion? A.Ant i- HBc( IgM) B.HbsAg C.Ant i- HBs D.Ant i- HBc( IgG) 42. Whatmar keri ndi cat esi mmuni tyt ohepat it isBi nfect ion? A.Ant i- HBc( IgM) B.HBsAg C.Ant i- HBs D.Ant i- HBc( IgG) 43.Anti bodi esi nwar m ant ibodyi mmunohemol yti canemi aar eusual l ydi rect ed against A.I B.P C.Ki dd D.Rh 44. Donat hLandst einerant ibodi esar eseeni n A.War m ant ibodyi mmunohemol yti canemi a B.Par oxy smal col dhemogl obi nur ia C.Par oxy smal noct urnal hemogl obi nur ia D.I mmunet hrombocy topeni cpur pur a 45. Anti bodyi npar oxy smal col dhemogl obi nur iai sdi rect edagai nstt hebl oodgr oup ant igen A.I B.P C.MNO D.Rh 46. Hemol yti cdi seaseoft henewbor ndev elopswi th A.Rh–v efet usi nanRh+v emot her B.Rh+v efet usi nanRh–v emot her C.Rh–v efet usi nanRh–v emot her D.Rh+v efet usi nanRh+v emot her 47.Themaint ypeofant ibodycausi ngwar m ant ibodyt ypeofi mmunohemol yti c anemiais A.I gA B.I gE C.I gM D.I gG 48. Coombst esti sposi ti vei n A.Al phat hal assemi a B.Si ckl ecel lanemi a C.Her edi tar yspher ocy tosi s D.I mmunohemol yti canemi a 49. Bombaybl oodgr oupi schar act eri zedbyabsenceof A.Agene B.Bgene C.Bot hAandBgene D.Hgene 50. Theser um ofani ndi vi dual wit hBbl oodgr oupcont ains A.Ant i- A B.Ant i- B C.Ant i- AandAnt i- B D.Ant i- D 51. Thebl oodgr oupi nABOsy stem, thatl acksant igenont heRBCmembr anei s A.A B.AB C.O D.B 52.I nhemoly ticdi seaseoft henewbor n,t heser um ofmot heri stest edf orRh anti bodi esby A.Di rectant igl obul i ntest B.I ndi rectant igl obul i ntest C.Cr ossmat chi ngwi thnewbor nbl ood D.AB, Rhposi ti ver edcel l s 53. Thefunct ionofadeni neintheant icoagul antci tr atephosphat edext rosef orbl ood col l ecti on,i nthebloodbankis: A.Topr eventcl ott ing B.Togener ategl ucose C.Tobuf fert heendpr oductofgl ycol ysi s D.Toactasasubst rat eforr edcel lsy nthesi sofATP 54.Pl atel etsar est oredat A.20°t o24° C B.–10° C+2° C C.–15° C+2° C D.–37° C+2° C 55. Thebl oodpr oductofchoi cef orv onWi l lebr anddi seasei s A.Pl atel ets B.Fr eshf rozenpl asma C.Whol ebl ood D.Cr yopr eci pit ate 56. Graf t- ver sus- hostdi sease( GVHD)i scausedwhen A.DonorTl ymphocy tesat tackhostt issues B.I mmunosuppr essi vet her apyi sincr eased C.Bl oodi str ansf usedf oll owi ngor gant ranspl ant ati on D.Ly mphocy tesar edepl etedi nthet ranspl antr eci pient 57. Whatt echni quesar enecessar yforweakDt est ing? A.Sal i ne+22° Cincubat ion B.Al bumi norLI SS+37° Cincubat ion C.Sal i ne+37° Cincubat ion D.37° Cincubat ion+I AT 58.Apat ienti ssuspectedofhavi ngpar ox y smalcoldhemogl obinuri a(PCH).Whi ch patt ernofreact ivi tyischar act eri sti coftheDonat h–Landst eineranti body ,which causest hiscondi tion? A.Theant ibodyat tachest oRBCsat4° Candcauseshemol ysi sat37° C B.Theant ibodyat tachest oRBCsat37° Candcausesaggl uti nat ionatt heI ATphase C.Theant ibodyat tachest oRBCsat22° Candcauseshemol ysi sat37° C D.Theant ibodyat tachest oRBCsandcausesaggl uti nat ionatt heI ATphase 59. Whichchar act erist icsar etr ueofal lthr eeoft hef oll owi ngant ibodi es: ant i- Fya, ant i- Jka,andant i- K? A.Det ectedattheIATphase;maycausehemol yti cdi seaseoft henewbor nand hemolyt ictr ansfusi onreacti ons B.Notdet ect edwi thenz yme- tr eat edcel l s C.Requi rest heI ATt echni quef ordet ect ion; usual l ynotassoci atedwi thHDN D.Enhancedr eact ivi tywi thenz yme- tr eat edcel l s; 60.Apati enttypesasABposi t ive.Twouni tsofbloodhavebeenorder edbythe physi ci an.Cur r entl y,theinv entoryshowsnoABuni t s,10A-posi ti veunit s,1A- negat iveunit, 5B-positi veunit s,and20O-posit iveuni ts.Whichshoul dbesetupf or themajorcrossmatch? A.A- posi ti veuni ts B.O- posi ti veuni ts C.B- posi ti veuni ts D.Cal lanot herbl oodsuppl i erf ort ype- speci fi c 61. FFPcanbet ransf usedwi thoutr egar dfor : A.ABOt ype B.Rht ype C.Ant ibodyi npr oduct D.Al loft heseopt ions 62. Whi choft hef oll owi ngi sanaccept abl eti mei nwhi chauni tofwhol ebl oodi s col l ect ed? A.33mi nut es B.25mi nut es C.20mi nut es D.13mi nut es 63.Par oxysmalcoldhemoglobi nur ia( PCH)i sassoci atedwi thant ibodyspeci fi cit y towardwhichofthefol l owing? aKel lsy stem ant igens bDuf fysy stem ant igens cPant igen dIant igen 64. Theenzy mer esponsi blef orconf err ingHact ivi tyont her edcel lmembr anei s al pha- : agal act osy ltr ansf erase bN- acet ylgal act osami nyl transf erase cL- fucosy ltr ansf erase dN- acet ylgl ucosami nyl transf erase 65. B 66. A 67. 25y ear -ol dpati enthasObl oodgroup, andarequestf ort wounitspackedRBCs hasbeenrecei vedWhichbl oodgroupshoul dbeusedint hecrossmatch? A.A B.Aorb C.O 68. ABOt ypi ngonpat ienti ndi cat esasubgr oupoft heA bl oodgr oup.whi chr eagent shoul dbeusedt oresol eanA subgr oup? A.Ant i- A B.Ant iA1 C.Ant iB D.Ant i- D 69. Aposi ti vedi rectCoomb’ stestmaybecausedbywhi choft hef oll owi ng? A.Mar kedr eti cul ocy tosi s B.I ntr avascul arhemol ysi s C.Congest ivehear tfai l ure D.Anaut oant ibodyonr edcel l ssur face 70.Whil ecross- mat chingABObl oodt ypes, whatt est susedt odet ermi newhencel l s arecoatedwit hanti bodies? A.Di rectcoombst est B.I ndi rectcoombst est C.posi ti vehet erophi l etest D.Ant ihumanI gGant ibodyt est 71.Gr oupOredbl oodcel l sar eusedasasour ceofcom mer cial scr eeni ngcel l s because: a.Ant i- Aisdet ect edusi nggr oupOcel l s b.Ant i- Dreact swi thmostgr oupOcel l s c.Weaksubgr oupsofAr eactwi thgr oupOcel l s d.ABOant ibodi esdonotr eactwi thgr oupOcel l s 72. Check( Coombscont rol )cel l sar e: a.Addedt oev erynegat iveant igl obul i ntest b.Addedt onegat ivedi rectant igl obul i ntest sonl y c.Usedt oconf ir m aposi ti veCoombs’ react ion d.Coat edwi thbot hIgM andC3d 73. Whatty pe( s)ofr edcel l sis( are)accept abl etot ransf uset oanAB- negat ive pat ient ? a.Anegat ive, Bnegat ive, ABnegat ive, Onegat ive b.Onegat iveonl y c.ABnegat iveonl y d.ABnegat ive, Anegat ive, Bnegat iveonl y 74. AnI gA-def ici entpat ientwi thcl i nical l ysi gni fi cantant i- IgAr equi reswhi choft he fol l owi ng? a.Leukocy te- reducedf reshf roz enpl asma b.CMV- ser onegat iveRBCs c.I rr adi atedRBCsandpl atel ets d.WashedRBCs 75..Ant i- Hwi l lreactweakestwi thbl oodf rom aper son _ ___wi th a.Gr oupO b.Gr oupA1 c.Gr oupA2 d.Gr oupA2B 76. Whi choft hef oll owi ngant ibodi esdonotmat cht he ot her sint ermsofopt imal react ivet emper atur e? a.Ant i- Fya b.Ant i- M c.Ant i- K d.Ant i- S 77. Whatant ibodycananR1rpat ientmakei ftr ansf usedwi thR2R2bl ood? a.Ant i- D b.Ant i- C c.Ant i- E d.Ant i- c e.Ant i- e 78. C 79.I faper sonhasthegenet icmakeupHh, AO, LeLe, sese, whatsubst ancewi l lbe foundi nthesecr eti ons? a.Asubst ance b.HSubst ance c.Leasubst ance d.Lebsubst ance 80.Bef oreAandBant igenscanbeex pressed, thepr ecur sorsubst ancemusthav e theter minal sugar. ___ ___ ___ __ a.d- Gal act ose b.N- Acet ylgal act osami ne c.Gl ucose d.L- Fucose 81.Awhitef emal e’ sRBCsgav ethef oll owi ngr eact ions: D+, C+, E-, c+, e+.Themost probabl e Rhgenot ypei s: a.DCe/ Dce b.DCe/ dce c.DCe/ DcE d.Dce/ dCe 82. Whi choft hef oll owi ngi sachar act eri sti coft heKi ddsy stem ant ibodi es? a.Theant ibodi esar eusual l yIgM b.Thecor respondi ngant igensar edest roy edbyenzy mes c.Theant ibodi esar eusual l yst rongandst abl edur ingst orage d.Theant ibodi esar eof teni mpl i cat edi ndel ayedhemol yti ctr ansf usi onr eact ions 83. Ant i- Ewi l lreactwi thwhi choft hef oll owi ngcel l s? a.RoRo b.R1R1 c.R2R2 d.r r 84.Donor swhohav erecei vedRBCt ransf usi onwi thi nthel ast12mont hsar edef err ed because: a.Bl oodcoul dtr ansmi thepat it isorHI V b.Donorr edcel lhemogl obi nlev elmaybet ool ow c.Donorheal thwoul dpr ohi bitt hedonat ionpr ocess d.Ther ewi l lbet wocel lpopul ati onsi nthi sdonor 85. Whi chst atementi snott rueconcer ningant i- Fyaandant i- Fyb? a.Ar ecl i nical l ysi gni fi cant b.Reactwel lwi thenzy me- tr eat edpanel cel l s c.Causehemol yti ctr ansf usi onr eact ions d.Causeagener all ymi l dhemol yti cdi seaseoft henewbor n 86. Whi chant ibodycoul dcausehemol yti cdi seaseoft hef etusandnewbor n? a.Ant i- I b.Ant i- K c.Ant i- Lea d.Ant i- N 87. Oft hef oll owi ng, whi chgenot ypeswoul dresul tint heBphenot ype? a.BB b.AB c.BO d.aandb e.aandc 88. B 89. B 90. Bloodgroupant ibodi esmadebyt ypeAandt ypeBpeopl ear epr edomi nant ly whi chclass? a.I gE b.I gA c.I gG d.I gM 91. D Ablooddonorcomest otheblooddonat ioncent er.Hesay shewi shest odonat ebl ood.An92. examinat ionofbot harmstherewereski nlesi ons? A.Def err aldonor B.Col l ectbl oodf rom donor C.Askdonort oret urnf rom donat ionaf ter2weeks D.Senddonort obl oodbankphy sici anf orev aluat ion 93.DATi susedt odowhat ? A.Det erminetheredcel lphenotype B.Demonstr ateinviv oAbcoat i ngofredcells C.Demonstr ateinvit roAbcoatingofr edcel l D.Det ecti ncompl et eanti bodiestopotent ialdonorr edcel l s 94.A17y ear -ol dsickl ecell pati enthastheA2bloodgroup,andar equestf ort wo uni tspackedRBCshasbeenr ecei vedattheBloodBank. Whichbloodgroupshoul dbeusedi nt hecrossmatch? A.A B.B C.AB D.O 95.i nfanthasRh+v e&motherRH- vemustgi ve? A.Anti -Dimmunoglubi n B.Anti -Eimmunogl ubin C.Anti -Aimmunoglubi n D.Anti -Cimmunoglubi n 96.CPDA1ant icoagul antt ost orebl oodf or? A.42days B.35days C.21days D.10days 97.Warm autoimmunehemol yti canemi aisusual l y causedbywhi choft hefol l owi ng? a.I gAantibodies b.IgGanti bodies c.I gM anti bodi es d.Complement 98.Whichofthef oll owingantibodi esdonotmatcht he other sintermsofopt imalreacti vetemper atur e? a.Anti -Fya b.Anti -M c.Anti -K d.Anti -S 99.Whi choft hef oll owingbestexplainswhyBombayi ndi vidualswit hthegenot ype (hh)mayi nheritABOgenes, yetfai ltoexpressthecor respondingredbl oodcell anti gens? A.It- 3-D-gal act osy l tr ansferaseisnotadded B.N-acetyl- Dgal actosami neisnotproduced C.L-fucoseisnotaddedt othetypetwochai n D.Bombayi ndividualsalsolackSesecretorgenes 100. A 101.Bl oodgr oupant ibodi esmadebytypeAandt ypeB peopl earepr edomi nantl ywhi chclass? a.I gE b.I gA c.I gG d.I gM 102.Coughi ng,cyanosisanddiff icul tbr eat hingar esy mpt omsofwhi choft he fol lowingtransf usi onr eact ions? A.ci rculat oryov erload B.mi xedfi eldposi ti ve C.accurat elyident i fythedonors D.RBC, l eukor educed 103.Whi chimmunodominantsugarconf ersAant igen specifi cit y? a.D-Galactose b.L-Fucose c.N-Acetylgal act osami ne d.BothAandC 104.I fapatienthasanA2ABOt y pe,whi chofthefoll owi ngstat ement sist rue? a.Thepat ient’ sredcell swillreactwit hanti -A1lect in b.Thepat ient’ sserum wil lreactwithA2cel ls c.Thepat ient’ sredcell swillreactwit hanti -A2lect in d.Thepat ient’ sserum wil lreactwithA1cel lsifant i- A1ispr esent 105.Whi chgenot ypeconf erst heBombaybl oodt ype? a.Hh b.hh c.Sese d.Lel e 106.Whichgenesencodef orRhant igens? a.RHDCE b.RHD c.RHCE d.Bothbandc 107.Whichi st r ueoft heDuffybl oodgr oupsy stem? a.Anti gensareresist anttoenzymet r eatment b.Anti bodi esnev ershowdosage c.FyaandFybarecodomi nantall eles d.Themajori tyofwhi t esareFy(ab) 108.Whichanti bodyi sty pical l yconsi der edt obeanaut oant ibodyi ffoundi nthe serum ofanadul t? a.Anti -K b.Anti -I c.Anti -D d.Anti -Fya 109.Whi chofthefol lowingistr ueoftheLewi ssy stem? a.Lewi santi gensarefoundontypeIIpr ecursorcell s b.Lewi santi gensarewelldevel opedatbirt h c.AntibodiestoLewisanti gensalwayscauseHTRs d.AntibodiestoLewisanti gensrarel ycrossthe placenta 110.Youhav eperformedanant ibodyscreenusingthe tubemet hod.Al lthreescreeni ngcel l stestednegati ve. TheCoombscheckcel lsinallthreetubesarealso nonreacti ve.Whatshouldy oudo? a.Respinthetubesandr ereadt hem b.Reporttheanti bodyscr eenasnegat i ve c.Repeattheantibodyscreen d.Perfor m anant i bodyidentif icat i onpanel 111.Anantibodypanelhassi x2+reacti vecel lsatAHG phase.Paneltest ingusi ngenzyme- treat edcell s showednor eacti vit y.Whichi sthemostli kel yanti bodythati spr esent ? a.Anti -Fya b.Anti -e c.Anti -k d.Anti -Lua 112.Ar ecentl ytr ansfusedpati enthasa3+reactiveDAT wit hant i- IgG.Whichprocedur eshouldbeusedt o i dentif yt hespecif ici tyoftheI gGantibodyat tached totheredcells? a.Adsorption b.Neutrali zati on c.Ti tr ati on d.El uti on 113.AnO- negati vemot hergav ebi r thtoanO- posi ti ve baby.Herrosett et estwasposit ive.Whichofthefoll owingist rue? a.Thetestisinval idbecauseofthemot her’ sABOt ype b.AKleihauer- Betketestshoul dbeper for medt oquanti fythefet almat ernal hemorrhage c.Themot hershouldbegi v ena300- mgdoseofRhI G 114.At raumapati entwi thtypeABisseenatarur alhospi tal.Thehospi tal onl yhas3 unit soft ypeABRBCs. Whatbl oodtypeofRBCscanthepat ientr ecei veas analternati ve? a.TypeO b.TypeB c.TypeA d.Noneoft heabove e.Alloftheabove 115.Mostbloodgroupant i gensar eex pressedasar esul t ofwhichofthefoll owing? A.Autosomalr ecessiv ei nheri tance b.X-l inkeddominanti nher i tance c.Y-l i nkedrecessiv einherit ance d.Autosomalcodominantinherit ance 116.HowcanI gGant ibodi esber emov edf rom r edcel l s? a.El ution b.Adsorpti on c.Prewarming d.Neutral i zati on 117.A“ di rect eddonor”unitofbloodisdefi nedasauni t ofbloodfrom apersonwhogi v esbloodf or : a.Reli efofpolycyt hemiaorotherblooddisorder b.Hisorherspecifi cuseonly c.Fi rst- degreebloodrel ati ve d.Anotherpersonheorshehasspeci fi ed 118.Thestor aget emper atur eforpackedr edbl oodcel l sis ____ _. a.1t o10C b.1t o4C c.1t o6C d.20t o25F 119.8.Thet emper atur efori ncubat ionoft hei ndi rectant igl obul i ntest( IAT)shoul d be____. a.24C b.6C c.37C d.37+-10C 120.Aphy sici anorders2unit sofleukocy te- reducedredbl oodcell s.Thepati entisa 55-year- oldmalewithanemia.HetypesasanABnegat i ve, andhisanti bodyscreeni s negativ e.Thereisonly1unitofABnegati veininvent ory.Whati sthenex tbl oodtype thatshouldbegiven? A.ABposi t ive B.Anegat iv e C.Bnegat i ve D.Onegat i ve 121.Whichhepat it isBmar keri sthebesti ndi cat orofear lyacut einf ect ion? A.HBsAg B.HBeAg C.Anti -HBc D.Anti -HBs 122.Awomanwant stodonat ebl ood.Herphysi cal examinat ionr eveal sthef oll owing: weight—110Ib, pulse—73bpm, bl oodpr essure—125/ 75mm Hg,hematocr it —35%.Whichofthef oll owi ngexcl usions appli estothepr ospect ive donor? A.Pulsetoohi gh B.Weighttool ow C.Hemat ocri tt oolow D.Bloodpressur etoolow 123.33. Previ ousrecor dsofpati ent s'ABOandRh ty pesmustbei mmediatel yav ail abl eforcompar isonwi thcur rentt estr esul ts A.For6mont hs B.For12mont hs C.For10years D.Indef ini tel y 124.Whichofthefol lowi ngweakDdonoruni tsshoul dbel abel edRh- posi ti ve? A.WeakDduet ot ransmi ssi blegenes B.WeakDasposi t ioneff ect C.Weakparti alD D.All theabove 125.Apatientwi thcol dhemaggluti nindisease (CHD)hasapositi veDATwhent estedwithapoly specif icAHG.Whi choft he fol lowingwouldmostl ikel ybedetectedonherredcel ls? A.IgM B.IgG C.IgA D.C3 126.Whichofthefoll owingbloodgroups react sleastst rongl ywi t hanant i -H producedinanAjBindi vidual ? A.Gr oupO B.Gr oupA2B C.Gr oupA2 D.Gr oupA1 127.Howmanygenesencodet hef oll owi ngRhant igens: D,C, E,c, e? A.One B.Two C.Three D.Four 128.Ift hepat i ent' sRBCswer et est edagai nst anti -Hlecti nanddi dnotreact ,thisper son wouldbei denti fi edasa(an) A.AcquiredB B.Ohphenot ype C.Secretor D.SubgroupofA 129.Aserum contai ningant i- kisnotfr equentl yencount ered.Thi sisbecause A.Peoplewholackthekantigenarer are B.Peoplewhopossesst hekanti genarerar e C.Thekant i genisnotagoodi mmunogen D.Kel lnull peoplearerare 130.Whi choft hefol lowingisacharacteri sti c ofKiddsy stem ant ibodies? A.UsuallyIgM anti bodies B.Correspondingantigensaredestroyedbyenz ymes. C.Usuallystrongandst abl eduringstorage D.Oftenimpl i catedindelayedhemol y tictr ansfusi onreact ions 131.Whichoft hefoll owi ngst at ement si snot tr ueofanti-Fyaandant i- Fy b? A.Arecli nicall ysignif icant B.Reactwel l withenz yme- tr eatedpanelcel l s C.Causehemol y tictr ansf usionreacti ons D.Causeagener al lymildhemol y tic di seaseoft henewbor n 132.Whichoft hefollowingstatement sisnot tr ueaboutant i -U? A.Iscl inical lysigni ficant B.Isonlyfoundi nblackindivi dual s C.OnlyoccursinS- s-indiv idual s D.OnlyoccursinFy (a-b-)i ndivi dual s 133.Whichoft hef oll owi ngi sgener all ydet ect edatt heant igl obul i nphaseoft est ing? A.Anti -Jka B.Anti -M C.Anti -Pj D.Ant i- I 134.Whichoft hebl oodgr oupsy stemsi sassoci atedwi thant ibodi est hatar e gener all yIgM? A.Rh B.Duff y C.Kel l D.Lewis 135.Thecrossmatchi sperformedusing A.Donor' sserum andr ecipi ent' sredcell s B.Donor' sredcel lsandreci pient 'sserum C.Donor' sserum andr eagentredcell s D.Recipi ent' sser um andreagentredcel ls 136.Whichofthefollowingwi l lthecrossmatchdo? A.Preventimmunization B.Preventdel ayedtransfusionreacti ons C.Guaranteenormalsurv i valoftheredbloodcell s D.Frequentl yveri fydonorABOcompat ibi l ity 137.Thepat ienti sgroupA.Whi chcr yopr eci pit ateuni tswoul dmostappr opr iat elybe usedtotr eatthi spati ent ? A.GroupAonly B.GroupABonly C.GroupAandGr oupO D.GroupAandGr oupAB 138.Whati sthecomponentofchoi ceforsomeonewhoneedsaRBCt ransf usi on whent hereisahist oryoffebri l et ransf usionr eacti ons? A.RBCsl essthan5day sold B.Leukocy t e-r educedRBCs C.RBCs30t o35day sol d D.FrozenRBCst hathavebeent hawedanddeglycerol i zed 139.Whi choft hefol l owingi st hecomponent ofchoicewhenaphy sici anisconcerned aboutrestoringormaintai ningoxygencar ryi ngcapaci ty? A.Albumi n B.Cryoprecipit ate C.Whol eblood D.Redbl oodcel l s 140.Occasi onal ly, patientshav eananaphy lact icreact iontoaspeci fi c i mmunogl obul in cl assduringatr ansfusion.Whi chi mmunoglobuli nclassismostoft en i mpl i cat ed? A.IgA B.IgD C.IgE D.IgG 141.Whichistheclassofimmunogl obul inuniquel yassociatedwithhemolyt ic di seaseofthenewbor n( HDN) ? A.IgA B.IgD C.IgE D.IgG 142.Aneonat ewithaposit ivedi rectanti globuli ntest( DAT)i ndi catesthatt herewas anincompatibil i tybetweenamot herandherf et us.Thesystem thati smost commonl yassociatedwi thanincompat i bil it yis A.ABO B.Rh C.Kell D.Kidd 143.Haemol yti cdiseaseofanew- bor ndevel opsduet othepassaget hef ol lowing anti bodies? A.igGant i bodiesfr om mat ernalcir cul at ionacrosst hepl acent at hef etalcir culati on B.IgM anti bodiesfrom maternalcirculati onacrosstheplathef etal ci r culati on C.IgGant i bodiesfr om fetalcir culationacrosstheplacentmater nalcircul ation D.I gM ant ibodiesfrom f etalcir culationacrosstheplacenmat ernalcirculat ion 144.Whi chcr it eri aar eusedi nsel ect ionofbl oodf orexchanget ransf usi oni nRhHaemol yti c Di seaseoftheNew-bornwhenABOi scompat ibl ewi tht hei nfant ? A.Blood>7dayold,Rh-posit ive B.Blood>7dayol d,Rh-negative C.Fr eshblood